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Embryonic Stem Cell Research Controversy:
Focus on the Private Sector and International
Sphere
Sylvia Kim·
The latest developments in stem cell research have sparked more
optimism and hope for people suffering from various maladies than any
other recent medical or scientific breakthroughs. I Stem cell research holds
the potential for treating virtually any disease and will eventually
revolutionize the way patients are treated and cured? It holds enormous
potential for finding cures for Parkinson's disease, heart disease, diabetes,
and numerous neurological disorders. 3 Until recently only animal stem
cells were used in research, thus ethical issues had not become a grave
concem.4 However, Dr. James Thomson at the University of Wisconsin
and Dr. John Gearhart at Johns Hopkins University isolated and cultured
human embryonic stem cells in 1998 by using privately funded
laboratories. s This ignited the long-standing ethical debate on when life
begins and the moral and ethical status of embryos.
This Note demonstrates the following likely consequences of current
federal and state regulations in the U.S. regarding stem cell research: (1)
The U.S. will hinder important life-saving research; (2) such research will
• J.D. Candidate, May 2002, University of California, Hastings College of the Law, B.A..
University of California. Berkeley (1997). I am deeply grateful to my husband, Doug Shin,
for his continuing love and support.
\. See Daniel Peny, Patients' Voices: The Powerful Sound in the Stem Cell Debate, 287
SCIENCE 1423, 1423 (2000) (suggesting that new developments in stem cell research may
help those suffering from various afflictions); James A. Thomson et aI., Embryonic Stem
Cell Lines Derivedfrom Human B1astocysts, 282 SCIENCE 1145, 1145-47 (1998).
2. See Stem Cell Research: Hearing Before the Subcomm. on Labor, Health & Human
Servs., Educ., & Related Agencies of the Senate Comm. on Appropriations, 105 th Congo 9-10
(1998) (prepared statement of Harold Varmus, M.D., Director, National Institutes of
Health); Thomson, supra note 1, at 1145-46.
3. See NATIONAL INSTITUTES OF HEALTH, STEM CELLS: SCIENTIFIC PROGRESS AND
FU11JRE RESEARCH DIRECTIONS i (200 I ).
4. Heather J. Kukla, Embryonic Stem Cell Research: An Ethical Justification, 90 GEO.
L.J. 503, 504 (2002).. .
5. National Institutes of Health, NIH Fact Sheet on Human Pluripotent Stem Cell
Research Guidelines, at http://www.nih.gov/news/stemcell/stemfactsheet.htm (Jan. 2001).
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continue with private funding without being scrutinized by the public
ethical research review mechanisms; and (3) such research will continue in
other countries as the U.S. is left behind the times.
Part I of this Note examines the background information including the
history and development of stem cell research. This part considers
different ethical theories regarding using embryos in stem cell research
starting with the source of controversy. It describes how stem cell research
shows appropriate respect for embryos and concludes that the medical and
scientific benefits expected from embryonic stem cell research justify using
embryos. Part II discusses the current state of federal and state law on stem
cell research.
Part III focuses on the private sector of stem cell research and
demonstrates the need for adequate safeguards and procedures to ensure
that the research is conducted within ethical parameters in the private
sector. Due to a lack of regulations other than in the funding context,
privately funded research remains virtually unregulated.
This part
emphasizes the importance of using federal funding as an incentive to bring
privately funded researchers into compliance with federal guidelines.
Part IV addresses the global advances made in stem cell research while
the U.S. federal government has been grappling with the ethical issues.
Without federal funding, the private sector left to its own resources will
only make slow progress compared to the rest of the world, and the U.S.
will fall behind.
Finally, the Note concludes that because withholding government
funds from stem cell research does not eliminate moral and ethical
objections, the U.S. should use federal funding to regulate the private
sector and achieve faster and more efficient progress. Federal funding
provides a solution for potential abuse in the unregulated, privately funded
research and a way to keep up with the rest of the world while still ethically
regulating the stem cell research.

I.

BACKGROUND: HISTORY AND DEVELOPMENT OF
STEM CELL RESEARCH

Embryonic stem cells have the unique ability to develop into all other
types of human cells and "are capable of unlimited, undifferentiated
proliferation in vitro.,,6 Although they cannot become an entire human
being, they can renew themselves and form many different cell types and
They could be used in cell, tissue, or organ
complex tissues. 7
transplantation therapies, regeneration of brain tissues, restoration of

6. National Institutes of Health, Stem Cells: A Primer, at http://www.nih.gov/news
Istemceillprimer.htm (May 2000).
7. Id.
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nervous control, and safer testing of experimental drugs. 8 The embryonic
stem cells are derived from excess frozen embryos created at fertility
treatment centers. 9 The embryos are frozen at the blastocyst stage after
sperm has fertilized the egg. IO
A.

SOURCE OF CONTROVERSY

Human embryonic stem cell research is controversial because
researchers must destroy the embryo in order to extract the stem cells. This
research renewed discussions about the origins of human life, which were
thoroughly examined in the context of abortion rights and embryonic
research for infertility treatment." However, the embryonic specimens
which researchers use in stem cell research are blastocysts, not fetuses. A
blastocyst is a hollow sphere formed after a few days into the embryo's
development after fertilization. 12 It is a cluster of cells that have
proliferated for six to seven days after fertilization. 13 The outer cell mass
eventually forms the placenta and the inner cell mass forms the human
body of the embryo.14 The inner cells are able to develop into almost any
cell type in the human body, although they do not have the ability to form
the tissues supporting the embryo in the uterus. IS It is the inner cells that
are extracted for embryonic stem cell research. 16
Thus, the embryonic stem cell research only uses a portion of a cell
cluster formed a few days after fertilization. "The bottom line has to be
that these cells in and of themselves are not capable of [developing into a
human without purposeful manipulation to achieve that end].,,17
Additionally, cryopreservation, the freezing and storing of human
embryos, further complicates the status of the embryos. 18 The frozen
embryo is neither alive nor dead, but in a completely different state
altogether. 19

8. See National Institutes of Health, supra note 5.
9. National Institutes of Health Guidelines for Research Using Human Pluripotent Stem
Cells, 65 Fed. Reg. 51,976 (Aug. 25, 2000) (corrected at 65 Fed. Reg. 69,951 (Nov. 21.
2000)).
10. John A. Robertson, In the Beginning: The Legal Status of Early Embryos, 76 VA. L.
REv. 437, 440 (1990).
II. Kukla, supra note 4, at 507.
12. National Institutes of Health, supra note 6.
13. Id.
14. Id.
15. Id.
16. Id.
17. Gina Koiata, Cells Acting Like Embryos: Growing a Person From a Cell Begs the
Question Where Life Begins, LONDON FREE PRESS, Apr. 17, 1999, at F7 (quoting Dr. John
Gearhart of the Johns Hopkins University School of Medicine).
18. Jason H. Casell, Lengthening the Stem: Allowing Federally Funded Researchers to
Derive Human Pluripotent Stem Cells from Embryos, 34 U. MICH. J.L. REFORM 547, 556
(2001).
19. Id.
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ETHICAL AND LEGAL ISSUES SURROUNDING RESEARCH

1. The Special Nature of the Embryo
The embryo is unique because it lacks cerebral activities that give rise
to consciousness and neurological characteristics ascribed to humans in the
special sense, despite exhibiting some characteristics of a living being. 20
Before determining whether embryonic stem cell research is ethically
problematic, the moral status of the embryo needs to be explored. Three
commonly articulated views provide a continuum on the status of the
embryo.21 The first view treats embryos as human persons with the same
moral status as a living person because the embryo has the potential to
develop into a human being. 22 This position, which is similar to the prolife view in the abortion debate,23 would prohibit all embryonic stem cell
research. 24 The second view asserts that embryos are merely clusters of
cells without certain essential human capacities such as consciousness or
sentience, and thus have no more moral status than any other human
tissue. 25 Under this view, almost no ethical limitations to stem cell research
exist. 26
The third view resis in between the extremes. 27 According to this view,
embryos deserve "respect" even though they lack moral status as full
human persons. 28 However, the nature of respect for the embryos is subject
to a wide range of interpretations because a precise definition does not
exist.
Although the National Bioethics Advisory Commission
(Commission), a group that in 1999 studied ethical issues surrounding
embryonic stem cell research at the direction of President Clinton, has
stated that while "the human embryo. . . deserves respect as a form of
human life, the scientific and clinical benefits of stem cell research should
not be foregone,,,29 the Commission did not give a precise definition of
respect. 30
The 1994 Human Embryo Research Panel (Panel) adopted the third

20. See generally LEE SILVER, REMAKING EDEN: CLONING AND BEYOND IN A BRAVE NEW
WORLD 41 (1997) (describing attributes of the embryo).
21. I NATIONAL BIOETHICS ADVISORY COMMISSION, ETHICAL ISSUES IN HUMAN STEM
CELL RESEARCH: REpORT AND RECOMMENDATIONS OF THE NATIONAL BIOETHICS ADVISORY
COMMISSION 49 (1999), available at http://www.georgetown.eduJresearchinrcbllnbac

Istemcell.pdf.
22. ld.

23. ld.
24. Kukla, supra note 4, at 518.
25. I NATIONAL BIOETHICS ADVISORY COMMISSION,
26. Kukla, supra note 4, at 518-19.
27. I NATIONAL BIOETHICS ADVISORY COMMISSION,
28. Kukla, supra note 4, at 519.
29. I NATIONAL BIOETHICS ADVISORY COMMISSION,
30. ld. at 49-51.

supra note 21, at 49.
supra note 21, at 50.
supra note 21, at xi.
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view and stated that embryo research should proceed. 31 The Panel
articulated that the "preimplantation embryo" should receive serious moral
consideration, but not the same consideration due infants or children.32
They argue that the embryo, as a developing form of human life, deserves
respect and . should be used in research only for the most serious and
compelling reasons. 33 The Commission also adopted this view. 34
2.

Medical and Scientific Benefits

Since the embryos deserve respect, but not full moral status, it becomes
necessary to determine whether the benefits of stem cell research outweigh
the respect due the embryo.35 To show respect for the embryo, the research
needs to be conducted only as a means to a sufficiently important scientific
or medical end. 36 Embryonic stem cell research has demonstrated its
potential to save numerous lives and alleviate suffering of many people.
Surely, such scientific breakthroughs are "sufficiently important."
Additionally, embryonic stem cell research falls along the "spectrum of
morally acceptable options for disposing of embryos within the parameters
of respect.,,3?
The Commission articulated potential uses for embryonic stem cell
research in 1999/8 and again in its June 2001 report issued at the request of
the Bush Administration. 39 Some of the medical and scientific benefits
include possible treatment of diseases such as Parkinson's disease,
Alzheimer's disease, heart disease, and kidney failure. 4o The National
Institutes of Health listed Parkinson's disease, diabetes, traumatic spinal
cord injury, Purkinje cell degeneration, Duchenne's muscular dystrophy,
heart failure, and osteogenesis imperfecta as diseases that could possibly be
treated by transplanting cells derived from human embryonic cells.41 The
National Institutes of Health concluded that stem cell research is
"important to developing innovative cell replacement strategies to rebuild
tissues and restore critical functions of the diseased or damaged human
body.'>42 Furthermore, the medical and scientific communities estimate that
over 100 million Americans are suffering from conditions that may be

31. 1 NATIONAL INSTITUTES OF HEALTH, REPORT OF THE HUMAN EMBRYO RESEARCH
50 (1994).
32. Id.
33. Kukla, supra note 4, at 519.
34. 1 NATIONALBIOETHICS ADVISORY COMMISSION, supra note 21, at xi.
35. Kukla, supra note 4, at 521.
36. Id.

PANEL

37. Id.
38. See

1 NATIONAL BIOETHICS ADVISORY COMMISSION, supra note 21, at l.
39. See NATIONAL INSTITUTES OF HEALTH, supra note 3, at 16-18.
40. 1 NATIONAL BIOETHICS ADVISORY COMMISSION, supra note 21, at 1.
41. NATIONAL INSTITUTES OF HEALTH, supra note 3, at 16.
42. !d. at 11.
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43
alleviated or cured through embryonic stem cell research.
The benefits of embryonic stem cell research are more than just
speculative uncertainties. To list a few examples, researchers in Israel
reported success in producing insulin with human embryonic stem cells in
44
July 2001.
In February 2001 researchers in the United States cured
45
Parkinson's disease in laboratory animals using embryonic stem cells.
Considering such promising uses of stem cell research to cure various
diseases, a compelling justification for stem cell research exists and it
appears to be at least comparable to the respect embryos are due. 46
A strict utilitarian calculus or the moral imperative of compassion
shows how the research may benefit people who are suffering.47 The
alleviation of suffering and saving of lives balanced against the avoidance
of harm to specific embryos by foregoing research yields. the conclusion
that the benefits outweigh any harm. Thus, stem cell research should be
allowed. 48 However, this view has been criticized for devaluing human life
at its earliest stage and thus possibly putting other vulnerable members of
society at risk of being victimized by eugenics or euthanasia. 49 The
opponents argue that the value of the embryo needs to be considered
beyond the utilitarian idea of "good for many" versus harm to one or a few
embryos. 50 However, the high number of patients suffering from diseases
that may be cured or treated through stem cell research more than justifies
the research based on the moral imperative of compassion. 51 Furthermore,
patient groups urge that research should proceed because of the tremendous
benefits to patients who suffer from diseases that could be alleviated
through embryonic stem cell research. 52
Contrary to what stem cell research opponents proffer, embryonic stem
cell research can show respect for the embryo, even though the embryo is
destroyed in the process. 53 Four possible scenarios face the leftover
embryos when excess embryos are created in fertility treatments: Donating
43. Perry, supra note I, at 1423.
44. Stem Cells Are Used to Produce Insulin, N.Y. TIMES, Aug. 1,2001, at A12.
45. See Paul Recer, Parkinson's Disease: Possible 'Cure' in Political Arena, ATLANTA
I.-CONST., Feb. 18,2001, at Cl.
46. Kukla, supra note 4, at 523.
47. See, e.g., Arthur Allen, God and Science, WASH. POST, Oct. 15,2000, (Magazine), at
8; National Coalition for Cancer Survivorship, Media Alert, NCCS Joins Efforts of Patients'
Cure to Advance Stem Cell Research, at http://www.cansearch.org/conferences/releases
/pr052099.htm (May 20, 1999).
48. Kukla, supra note 4, at 526.
49. Frank E. Young, A Time for Restraint, 287 SCIENCE 1424, 1424 (2000). "The
devaluation of humans at the very commencement of life encourages a policy of sacrificing
the vulnerable that could ultimately put other humans at risk, such as those with disabilities
and the aged, through a new eugenics or euthanasia." /d.
50. Kukla, supra note 4, at 525.
51. Id.
52. /d.
53. Id. at 526.
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the embryo for gestation; permanently storing it; discarding it; or donating
it for research. 54 Gamete providers may consider the option of discarding
the embryo or donating it for research only after they have eliminated the
adoption and storage options voluntarily, without any input from
researchers. 55 Between the two options of discarding the embryo or
donating it for research, more respect may be shown through research by
alleviating the suffering of many people and possibly prolonging their
lives. Using the embryo in research to benefit other suffering individuals is
clearly an act that demonstrates valuing human life. 56 "This promotes life
in a way that simply discarding embryos, the source of potential alleviation
of suffering, cannot.,,57 Even pro-life Republican Senator Orrin Hatch has
stated that the stem cell research facilitates life and that helping people
suffering from maladies is the most pro-life position, far more ethical than
abandoning or discarding stem cells. 58
3.

Alternatives to Embryonic Stem Cell Research

If alternatives can provide the same benefits as embryonic stem cell
research it becomes harder to justify the use of embryos in light of the
ethical controversy surrounding embryonic stem cell research. 59 If no
alternative of equal potential exists, it should be easier for opponents to
accept embryonic stem cell research. 60
Opponents of embryonic stem cell research have offered some
alternatives. 61 One strong alternative is using adult stem cells instead of
embryonic stem cells. 62 Adults have a small number of stem cells in
certain types of tissues such as bone marrow or umbilical cord blood. 63
These stem cells can give rise to different types of cells in the body.64 For
example, hematopoietic stem cells, found in bone marrow and umbilical
cord blood, can tum into all types of blood cells in the adult human body.65
Also, recent research revealed that mouse skeletal muscle cells could give
rise to blood cells,66 and the use of bone marrow stem cells can repair heart
damage in rodents that suffered heart attacks. 67
54. See I NATIONAL BIOETHICS ADVISORY COMMISSION, supra note 21, at 49.
55. Kukla, supra note 4, at 529-30.
56. Id. at 530.
57. Id.
58. Ceci Connolly, Conservative Pressure for Stem Cell Research Builds, WASH. POST,
July 2, 2001, at AI.
59. Kukla, supra note 4, at 531.
60. Id.
61. Id.
62. Id.
63. National Institutes of Health, supra note 6; Kukla, supra note 4, at 532.
64. See National Institutes of Health, supra note 6.
65. I NATIONAL BIOETHICS ADVISORY COMMISSION, supra note 21, at 12.
66. Rick Weiss, In Cell 'Alchemy, ' an Alternative to Embryo Studies, WASH. POST, Apr.
24,2000, at All.
67. Nicholas Wade, Findings Deepen Debate on Using Embryonic Cells, N.Y. TiMES,
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However, nobody has been able to prove that adult stem cell research
will provide all the benefits of embryonic stem cell research. 68 Rather, the
National Institutes of Health researchers have concluded that stem cells in
adult tissues do not have the same capacity to differentiate into all other
types of cells as compared to embryonic stem cells. 69 Additionally, other
concerns including risks to the donor and the practicality of obtaining adult
stem cells hinder the feasibility of adult stem cell research. 7o Adult stem
cells are riskier to retrieve, especially from brain or bone marrow/ 1 and
they exist only in small quantities.72 They are harder to isolate/ 3 and their
availability is likely to decrease with the donor's age. 74 Also, researchers
have expressed concerns about adult stem cells being genetically old; adult
stem cells would have accumulated mutations and other damage throughout
the donor's lifetime. 7s Further, patients suffering from acute diseases
would not have sufficient time to retrieve the cells from their own body and
grow them in culture for successful treatment. 76 The embryo stem cells are
better suited for research because they divide quickly and are capable of
developing into almost all other types of cells in the body.77
Another suggested alternative considers other sources for embryonic
stem cells. 7s Instead of using stem cells derived from spare embryos
created for in vitro fertilization purposes, this option contemplates using
stem cells derived from embryos created in vitro specifically for research
purposes. 79 However, this alternative has been criticized as not giving

Apr. 3,2001, at Fl.
68. Letter organized by the American Society for Cell Biology from Alliance for Aging
Research et aI., to President-Elect George W, Bush (Jan, 17,200 1)(on file with author),
69, NATIONAL INSTITUTES OF HEALTH, supra note 3, at ES-9,
70. I NATIONAL BIOETHICS ADVISORY COMMISSION, supra note 21, at 57-59 (explaining
that harvesting adult stem cells is difficult and risky to human beings and causes pain and
discomfort); see also National Institutes of Health, supra note 6. "[Blrain cells from adults
that may be neuronal stem cells have only been obtained by removing a portion of the brain
of epileptics, not a trivial procedure." [d,
71. See I NATIONAL B(OETH(CS ADVISORY COMMISS[ON, supra note 21, at 57-58
(explaining that bone marrow extraction causes pain and discomfort and that brain biopsy
poses significant risks to the donor),
72, NATIONAL INSTITUTES OF HEALTH, supra note 3, at ES-6.
73. !d. "[A]dult stem cells are dispersed in tissues throughout the mature animal and
behave very differently." [d. at 23.
74. National Institutes of Health, supra note 5,
75. Weiss, supra note 66; see also National Institutes of Health, supra note 6 (noting that
if a genetic defect caused the disorder in a patient, it may also be present in the patient's
stem cells and that DNA mutations from exposure to toxins may be present in the stem
cells).
76. See Weiss, supra note 66,
77. See Casell, supra note 18, at 551-52 (stating that embryonic stem cells can generate
most of the specialized cells and tissue of the body and that adult stem cells may be able to
divide only a limited number of times).
78, Kukla, supra note 4, at 535.
79, [d.
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proper respect to embryos.80 Creating an embryo for reproduction is
respectful of the embryo as a form of human life, but creating an embryo
just for research purposes is not. 81 This alternative violates the Kantian
imperative of not using a person solely as a means to an end. 82 In addition,
this method devalues the sanctity of the procreative process and intent to
create a child, and implies that the value of the embryo is found in its status
as a research subject, not in its status as a symbol of human life. 83
As illustrated above, the suggested alternatives do not provide equal
benefits, yet they are as ethically problematic as embryonic stem cell
research. The benefits of adult stem cell research are insufficient to pursue
adult stem cell research as an alternative to embryonic stem cell research.
Deriving stem cells from embryos created for research purposes poses as
serious, if not more serious, ethical problems. Considering these options,
or lack thereof, proceeding with the embryonic stem cell research is the
favorable option.

II. CURRENT FEDERAL AND STATE LAW
The latest controversy over stem cell research concerns the issue of
whether federal funding should be available for research that uses existing
embryonic stem cell lines, and not the derivation of new stem cells from
early human embryos.84 Although federal law currently prohibits the
funding of research that poses a risk to embryos,85 proponents of embryonic
stem cell research argue that the ban does not apply to research that uses
independently cultured stem cells, which are not embryos as defined by the
Department of Health and Human Services. 86 Federal funding has
tremendous impact on the progress of embryonic' stem cell research.
Embryonic stem cell research, in tum, has a potentially larger impact on the
practice of medicine and the lives of people suffering from currently
incurable diseases or conditions. Federal funding would ensure that both
privately and publicly funded scientists have an opportunity to unlock the
full potential of embryonic stem research. Perhaps the controversy exists
because so much is at stake.

80. Id at 537.
81. Id.
82. See I NATIONAL BIOETHICS ADVISORY COMMISSION, supra note 21, at 56
(hypothesizing that the creation of embryos solely for research purposes will result in
conceptualizing them as merely a means to an end).
83. Kukla, supra note 4, at 538.
84. Gabriel S. Gross, Federally Funding Human Embryonic Stem Cell Research: An
Administrative Analysis, 2000 WIS. L. REv. 855, 860 (2000).
85. See Omnibus Consolidated and Emergency Supplemental Appropriations Act, Pub.
L. No. 105-277, § 511{a), 112 Stat. 2681 (1998).
86. See National Institutes of Health, supra note 5 (explaining that the Department of
Health and Human Services (DHHS) found that federal law does not prohibit DHHS funds
from being used for research on human pluripotent cells because they are not embryos).
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A. THE HISTORY OF FEDERAL POLICY ON HUMAN EMBRYO RESEARCH
When Congress passed the National Institutes of Health Revitalization
Act of 1993 ("Revitalization Act"), it amended the existing federal
regulations governing research on human embryos.87
Prior to the
amendment, federal regulations required such research to be reviewed and
approved by an ethical advisory board before it might proceed. 88 The
Revitalization Act reversed the conditions for in vitro fertilization research
by letting the research go forward unless disapproved. 89
In 1994, the National Institutes of Health and the Department of Health
and Human Services convened an ethical advisory board, known as the
Human Embryo Research Panel, and established standards for acceptable
research for funding. 90 Their report sparked controversy by concluding that
researchers might ethically create embryos solely for research purposes
through in vitro fertilization. 91 Although the Advisory Committee formally
approved the recommendations, President Clinton banned the use of federal
funds for human embryo research and prohibited the National Institutes of
Health from allocating any resources in 1994.92 Based on this presidential
declaration, National Institutes of Health Director Harold Varmus
concluded that embryonic stem cell research still might be funded if the
embryos had been donated and not created solely for the purpose of
research. 93
However, before the National Institutes of Health reached a funding
decision, Congress attached a rider to that year's Department of Health and
Human Services appropriation bill that effectively prohibited federal
funding of any further human embryo research. 94
The rider to the appropriations bill, the Omnibus Consolidated and
Emergency Supplemental Appropriations Act (OCESAA), states
that none of the funds appropriated may be used to support
research which involves: (1) creation of a human embryo or
embryos for research purposes; or (2) research in which a human
embryo or embryos are destroyed, discarded, or knowingly
subjected to risk of injury or death greater than that allowed
for research on fetuses m utero under 45 C.F.R.
46.208(a)(2) and section 498(b) of the Public Health

87. Doe v. Shalala, 862 F. Supp. 1421, 1424 (D.M.D. 1994).
88. Jd.
89. Jd.
90. See id. at 1424-25; Meeting of Panel/Request for Public Comment, 59 Fed. Reg.
28,874,28,875 (June 3, 1994).
91. 1 NATIONAL BIOETHICS ADVISORY COMMISSlON, supra note 21, at 34.
92. William J. Clinton, Statement on Federal Funding of Research on Human Embryos, 2
PUB. PAPERS 19942142 (Dec. 2, 1994).
93. Gross, supra note 84, at 865.
94. Id.
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Services Act (42 U.S.C. 289g(b».95
Because embryonic stem cell research destroys the blastocyst in the
process of extracting the stem cell, federal funds have not been allocated to
support such research. 96 However, the OCESAA rider did not ban the
funding of embryo-related research that poses no risk to an embryo.97
Research using embryonic stem cells already isolated from the embryo
does not destroy or pose risk to an embryo.98
In 1998, after breakthroughs in the field of embryonic stem cell
research, President Clinton requested that the National Bioethics Advisory
Commission review the medical and ethical issues surrounding human stem
The National Bioethics Advisory Commission
cell research. 99
recommended responsible funding of such research,lOo and the Department
of Health and Human Services issued its interpretation of federal law and
opinion that funding embryonic stem cell research is permitted. 10 J

B.

THE DEPARTMENT OF HEALTH AND HUMAN SERVICES'
INTERPRETATION OF FEDERAL REGULATIONS WITH RESPECT TO
FUNDING EMBRYONIC STEM CELL RESEARCH

Due to the highly charged political climate, the National Institutes of
Health requested a legal opinion from the Department of Health and
Human Services to determine whether research on embryonic stem cells
would be considered research on embryos with respect to the federal
funding ban. 102 In early 1999, the General Counsel for the Department of
Health and Human Services opined that embryonic stem cells are not a
human embryo within the statutory definitions. 103 The federal ban on
human embryo research defines an embryo as an "organism" which is not
already protected under Department of Health and Human Services
regulations, but is derived by any process in which sperm meets egg. 104
However, stem cells derived from the blastocyst are not an "organism"
because they cannot become a fetus, even if implanted into a uterus. IOS

95. Jd (citations omitted) (quoting Omnibus Consolidated and Emergency Supplemental
Appropriations Act, Pub. L. No. 105-277, § 511(a), 112 Stat. 2681 (1998».
96. Gross, supra note 84, at 866.
97. Jd.
98. Jd
99. See 1 NATIONAL BIOETHICS ADVISORY COMMISSION, supra note 21, at Letter of
Transmittal to the President.
100. See id. (suggesting that limitations be placed on researchers who receive federal
funds).
WI. Gross, supra note 84, at 867.
102. See I NATIONAL BIOETHICS ADVISORY COMMISSION, supra note 21, at 35 (National
Institutes of Health Director Harold Varmus sought the opinion of DHHS General Counsel
Harriet S. Rabb).
103. Gross, supra note 84, at 867.
104. See id.
105. See National Institutes of Health, supra note 5; Kolata, supra note 17.
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These stem cells lack the capacity to become a fetus after they are extracted
from an embryo. Therefore, they do not constitute an embryo once they are
removed, resulting in destruction of the embryo.l06 Thus, the National
Institutes of Health may fund embryonic stem cell research, provided that
the research uses embryonic stem cells derived by privately funded
researchers. 107
In August 2000, the National Institutes of Health released guidelines on
conducting stem cell research in an ethical manner. 108 These guidelines
provided that, in order to obtain federal funding, embryonic stem cells must
be derived from spare embryos from in vitro .fertilization treatments, not
from embryos created for research purposes.109 The guidelines also
prohibited the use of monetary inducements for the donation of embryos. 110
In 200 I, the Bush Administration postponed a meeting of the Human
Pluripotent Stem Cell Review Group to review the first applications for
research grants under the new guidelines. III Although it was not clear
whether Bush issued the order, the postponing of th.e meeting was viewed
as the Bush Administration's intent to reconsider the issue of federal
funding of embryonic stem cell research. I 12 A federal district court in the
District of Columbia confirmed this halt in funding when it issued an order
temporarily stopping federal funding until completion of the Bush
Administration's review. I 13 In response to a request by the Bush
Administration, the National Institutes of Health released its report, which
is considered the most authoritative assessment of the medical and
scientific potential, as well as uncertainties, of embryonic stem cell
research. 114 The report concluded that stem cells from both adult sources
and embryonic sources demonstrate tremendous potential for treating
various diseases and conditions, and recommended that both types of
research be allowed to proceed. ~ 15

106. Kukla, supra note 4, at 508.
107. JUDITH A. JOHNSON & BRIAN A. JACKSON, STEM CELL RESEARCH, CONGo RESEARCH
SERVo REp. No. RS20523 (Sep. 19, 2000), available at http://www.cnie.org/nle/CRSreports
/Science/st-53.cfm.
108. National Institutes of Health Guidelines for Research Using Human Pluripotent Stem
Cells, 65 Fed. Reg. 51976 (Aug. 25, 2000).
109. See id. at 51,977 (noting that prior receipt of funds and documentation must be
provided demonstrating that embryos were created for fertility treatment).

110. Jd.
Ill. Rick Weiss, Bush Administration Order Halts Stem Cell Meeting, WASH. POST, Apr.
21,2001, at A2.

112. Jd.
113. Kukla, supra note 4, at 510 (citing Nightlight Christian Adoptions V. Thompson, No.
1.0lCV00502 (D.D.C. May 4,2001)). "Judge Lamberth issued an order temporarily halting
federal funding of embryonic stem cell research until completion of the Bush
Administration's review." Jd.
114. See NATIONAL INSTITUTES OF HEALTH, supra note 3, at i-ii.
115. See id. at ES-IO (explaining that both adult and embryonic stem cells can repair or
replace damaged tissue and suggesting that more research be conducted to detennine the
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In August 200 I, President Bush finally decided to allow funding of
embryonic stem cell research on existing stem cell lines where the life-anddeath decisions have already been made. 116 According to the National
Institutes of Health estimates, over sixty stem cell lines existed in 2001. 117
Consequently, federal funding is not available for research on any stem
cells that had not been developed into cell lines at the time of Bush's
announcement. 118 President Bush also mandated that a President's Council
be established to monitor stem cell research. 119
Although any funding is a significant step toward realizing the full
potential of embryonic stem cell research, President Bush's decision
received mixed reactions. 120 Some proponents of the research criticized the
President for doing the bare minimum to publicly posture himself with the
majority of Americans, but stopping short of full support for the
research. 121 As of now, all of the regulations and statutes governing stem
cell research pertain only to the funding context. 122
C.

STATE AND LOCAL LAWS

Meanwhile, state legislatures have been actively involved in the
embryonic .stem cell research debate. Almost two dozen states have
enacted laws that address research on embryos and at least nine states ban
all experimentation on human embryos.123 Some of the laws were enacted
decades ago in response to the 1973 Supreme Court decision legalizing

similarities and differences between the two types of cells).
116. See Address to the Nation on Stem Cell Research from Crawford, Texas, 37 WEEKLY
COMPo PRES. Doc. 1149 (Aug. 9, 2001).
117. Nicholas Wade, U.S. Approves Labs with Stem Cells for Research Use, N.Y. TiMES,
Aug 27, 2001, at Ai. However, researchers from several of the companies cited questioned
the number and viability of those lines. See Ceci Connolly & Rick Weiss, Stem Cell
Colonies· Viability Unproven, WASH. POST, Aug. 28, 2001, at Al (indicating that a key
scientist at Goteborg University in Sweden, whose cell lines were identified by the NIH,
was "a little surprised to see the NIH calling them 19 lines. Maybe they misinterpreted a
little bit;" and indicating that a researcher from an Indian company stated that only three of
the company's seven cell lines cited by the NIH had cleared the first hurdles in proving that
they were useful as stem cells). Several of the cell lines identified by the NIH may not
receive FDA approval for use in human treatments because they may have been mixed with
mouse cells for research purposes to help the human embryonic stem cells stay healthy. See
Justin Gillis & Ceci Connolly, Stem Cell Research Faces FDA Hurdle. WASH. POST, Aug.
24,2001, at Al (stating that many of the cell lines cited in President Bush's August 9, 2001
count of sixty-four viable cell lines were "created for early-stage research with no thought
that they would become the only embryonic cells eligible for federal money").
118. Kukla, supra note 4, at 515.
119. Address to the Nation on Stem Cell Research from Crawford, Texas, supra note 116,
at 1149.
120. See Amy Goldstein & Mike Allen, Bush Backs Partial Stem Cell Funding, WASH.
POST, Aug. 10,2001, at Ai.
121. Id.
122. Kukla, supra note 4, at 509.
123. Sheryl Gay Stolberg, Washington Not Alone in Cell Debate, N.Y. TIMES, July 23,
2001, at A12.

102

HASTINGS WOMEN'S LAW JOURNAL

[Vol. 14: 1

abortion. 124 South Dakota went one step further, making it a misdemeanor
to conduct non-therapeutic research on embryos at any stage. 125 This
precludes any embryonic stem cell research. 126
Also, some state statutes are broad enough to be interpreted to prevent
payment for cell lines developed from embryonic stem cells,127 effectively
prohibiting any stem cell research. Because the Department of Health and
Human Services recommended that federally funded researchers should
follow state and local laws, 128 researchers must comply with the laws of the
state in which they conduct the research. As a result, the state statutes have
carved out a significant place in the stem cell research regulation
scheme. 129

III. THE PRIVATE SECTOR
Because no federal regulations exist outside of the funding context,
privately funded researchers are currently virtually unregulated. The recent
breakthroughs in stem cell research such as the studies by the University of
Wisconsin and Johns Hopkins University have all resulted from privately
funded research projects. 130 These privately funded advances in research
demonstrate that human stem cell research will occur in the private sector
regardless of the availability of federal funding. I3l Although private
research is hindered by economic limitations, the scope of private research
is not restricted by the federal government. 132
The Geron Corporation is a leading biotech company that supports
three different research facilities nationwide. 133 As one of the forerunners
in stem cell research, James Thomson at the University of Wisconsin in
Madison has developed stem cell lines using private funds from Geron.134
Thomson and his team of researchers isolated the stem cells from embryos
and developed stem cell lines that retained the characteristics of human

124. ld. (referring to Roe v. Wade, 410 U.S. 113 (l973)).
125. S.D. CODIFIED LAWS §§ 34-14-16,34-14-20 (Michie Supp. 2001).
126. ld.; Kukla, supra note 4, at 517.
127. 1 NATIONAL BIOETHICS ADVISORY COMMISSION, supra note 21, at 36. It may be
possible that these laws which were intended to prohibit sale of embryonic tissue do not
apply to cell lines created from embryonic stem cells since a "cell line is new tissue
produced from the genetic material of, but not originally a part of, the embryo." Id.
(quotation marks omitted).
128. JOHNSON & JACKSON, supra note 107.
129. See Kukla, supra note 4, at 517.
130. See Gross, supra note 84, at 867.
131. ld. at 883.
132. Shirley 1. Wright, Human Embryonic Stem-Cell Research: Science and Ethics, 87
AM. SCIENTIST 352, 352 (1999) (noting that stem cell research is perfonned only by private
companies without any institutional oversight).
133. !'lelle S. Paegel, Note, Use o/Stem Cells in Biotechnological Research, 22 WHITTIER
L. REV. 1183, 1189 (2001).
134. Wright, supra note 132, at 352.
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embryonic stem cells. 135 Because these cells can multiply while remaining
undifferentiated, Thomson has created a ready supply of stem cells without
the need to sacrifice more embryos. Thus, ethical problems are minimized
by Thomson's method. Geron acquired an enviable position of potentially
controlling other research to some degree. 136 The advantage of possessing
a ready supply of stem cells is especially significant considering President
Bush's August 2001 announcement that funding would be available for
embryonic stem cell research on existing stem cell lines only where the
·life-and-death decisions have already been made.
Two other leading research facilities funded by Geron include John
Gearhart's team at Johns Hopkins University School of Medicine in
Maryland, which utilizes primordial germ cells, and Roger Pedersen's team
at University of California, San Francisco, which extracts stem cells from
the inner cell mass of the blastocyst. 137
Also at Johns Hopkins, Dr. Curt Civin has created various types of
blood cells needed for treatment of certain blood diseases from adult bone
marrow stem cells. 138 He has patented the techniques for separating and
using bone marrow stem cells. 139 Dr. Civin is working toward using a
patient's own stem cells to regenerate disease-free blood cells to replace
bone marrow cells destroyed in treatment processes such as chemotherapy
or radiation treatment for cancer. 140 Such technology may not only
eliminate the danger of host rejection, Graft Versus Host Disease, or reinfection of diseased cells involved .in procedures such as bone marrow
transplant; 14 I it might very well produce cures for all kinds of blood
diseases. 142
Another researcher at Johns Hopkins, Dr. Jeffrey Rothstein, is
experimenting with replacing damaged nerve cells in paralyzed lab
animals. 143 With a goal of treating diseases like amyotrophic lateral
sclerosis, which affects about 20,000 Americans, Dr. Rothstein intends to
start feasibility and safety studies with human patients within the next three
years. 144
Advanced Cell Technology, another company actively involved in
human genetic stem cell research, views cow and pig embryo stem cells as

135. ld.
136. Paegel, supra note 133, at 1190.
137. Wright, supra note 132, at 354.
138. See Johns Hopkins U. v. Cellpro, 931 F. Supp. 303, 308 (D. Del. 1996); Paegel, supra
note 133, at 1191.
139. Paegel, supra note 133, at 1191.
140. ld.
141. ld.
142. ld.
143. ld.
144. See Robert Lee Hotz, Adult Tissue Can Yield Stem Celis, Researchers Say. L.A.
TIMES, Nov. 6, 2000, at AI.
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a likely source for human organ transplants. 145 To make organs produced
from cow and pig embryo stem cells compatible with humans, researchers
are working on genetically altering animal embryonic stem cells. 146 The
human body's natural rejection of foreign material stands as the biggest
obstacle to successfully transplanting hearts or kidneys from pigs. 147
Researchers are trying to genetically alter animal embryonic stem cells to
generate cells that would be compatible with human tissue. 148 This type of
research clearly falls outside the scope of federal funding guidelines
recommended by the NIH because it entails "co-joining human and animal
tissue.,,149 Thus, federal funding is not available for such research.
However, as shown here, lack of federal funding has not dampened the
private sector's spirit.
Some researchers have even used cadavers in human stem cell
research. 150 Fred H. Gage and other scientists at the Salk Institute in
California are reviving neurons from ,dead brains by using cadaver brain
stem cells. lSI Gage has also succeeded in extracting skin and bone stem
cells and turning them into nerve cells. 152 He used tissues taken primarily
from children soon after their death for these projects. IS3
If research continues to proceed, through private funding it will
potentially remain unregulated by the federal government and largely
unknown to the public. 154 The prospect of federal funding provides a
strong incentive for privately funded independent research organizations to
conform to federal guidelines and regulations to, obtain access to the vast
resources of the federal government. 155 In return, compliance with federal
guidelines and regulations offer the benefit of strictly enforced oversight
processes which are absent in the privately funded research context. 156 The
possibility of jointly funded projects by the government and private
research institutions will reduce reliance on private funds and encourage
'
'
compliance with federal regulations. 157
On the other hand, withholding federal funding from embryonic ste,m
cell research would not resolve or forestall the moral and ethical objections

145. Paegel, supra note 133, at 1192.
146. Wright, supra note 132, at 358-59.
147. Paegel, supra note 133, at 1192.
148. Wright, supra note 132, at 358-59.
149. National Institutes of Health Guidelines for Research Using Human Pluripotent Stem
Cells, 65 Fed. Reg. 51,976 (Aug. 25, 2000) (corrected at 65 Fed. Reg. 69,951 (Nov. 21,
2000».
150. Paegel, supra note 133, at 1192.

151. ld.
152. !d.
153. Jamie Talan, The Origin o/Neurons, NEW YORK NEWSDAY, Nov. 7,2000, at C9.
154. Gross, supra note 84, at 883.

155, ld.
156. ld.
157. ld.
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expressed by the opponents of such research. It might even indirectly
encourage unethical research practices. 15S Without federal funding and the
essential checks and balances that accompany that funding, embryonic
stem cell research will only continue in the private sector where it is not
subject to government oversight. 159 The potential for unethical research
could only increase in such an environment..

IV. THE GLOBAL RESPONSE TO STEM CELL RESEARCH
The U.S. lags behind other countries in the embryonic human stem cell
biotechnology race. 160 While the United States has been grappling with
ethical issues, the rest of the· world has been busy moving forward with
stem cell research, claiming their stake in this new frontier.
In Scotland, where Dr. Ian Wilmut cloned Dolly the sheep,
biotechnology companies and universities are discussing collaboration to
clone embryos as a source of stem cells. 161 They are trying to assemble a
team of commercial and academic partriers. Geron Corporation, an
American company, is one of these partneis. 162
Great Britain, one of the first countries to permit the use of human
embryos in medical research,· publicly .announced that its Chief Medical
Officer endorsed the use of embryonic stem cells for research into tissue
and organ regeneration. 163 Although Parliament has yet to decide the issue,
most experts believe it will decide in the favor of allowing such research. l64
In Japan, the Council for Science and Technology, Japan's highest
advisory group for science, is on the verge of approving guidelines for
embryonic stem cell research: Researchers at Tokai University have
already cloned a piglet successfully through xenotransplantation. These
Japanese researchers believe that cloned pig organs can be transplanted to
replace diseased human organs. . They· hope to genetically alter the
immunological make-up in the cells that are used to create the clones to
trick the human body into accepting pig transplants, thereby eliminating
.
hostrejection. \ 6 5 '
In France, Dr. Marc Peschanski at Institut National de la Sante et de la
Recherche Medicale (INSERM), "the French equivalent of our NIH, has

158. Id
159. Id
160. See Gretchen Vogel, Stem Cells: New Excitement, Persistent Questions, 290 SCIENCE
1672, 1672 (2000); Gretchen Vogel, Stem Cell &orecard, 290 SCIENCE 1673, 1673 (2000).
161. Robert Frank & Ralph T. King, Jr., Creator of Dolly Seeks Partners to Clone
Embryos, WALL ST. J., Jan. 21, 1999, at B6.
162. Paegel,supranote 133,at 1193.
163. Id at 1194.
164. Stephen D. Moore, u.K. Urged to Boost Stem-Cell Research, WALL Sr. J. EUR., Aug.
17,2000, at I.
165. Charles W. Henderson, Cloned Piglet Sets Stage for Genetically Modified Organ
Transplants, BLOOD WKLY., Aug. 31, 2000, 2000 WL 24961840.
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been partially successful in treating Huntington's Chorea using fetal brain
cells.,,166 Five patients suffering from Huntington's Chorea had fetal stem
cells implanted on the sides of their brains. 167 Two years later, three
patients showed significant improvement, although more research is needed
to determine the possible effects of tampering with the brain during
surgery. 168
In Holland, Pharming, a Netherlands pharmaceutical company, and
Infigen, a small Wisconsin company, successfully cloned seventeen
Holstein cows in a combined effort with the Red Cross.169 The seventeen
cows have identical genetic make-up because they are copies created in a
lab dish from a modified cow embryo.l7O The goal of this research is to
have the cows produce milk that naturally contains the proteins commonly
used to treat hemophilia and other severe bleeding disorders. I7I If
successful, Factor VIII, a costly fibrogen that stops traumatic bleeding in
hemophiliacs, will be available for significantly less as a component in the
milk. I72 Pharming and the Red Cross plan to petition the Food and Drug
Administration for approval of the cows as manufacturers of drugs. 173
The National Institutes of Health guidelines prohibit conjoining human
and animal cells. Thus, federal funding is not available to Infigen or
Advanced Cell Technology for this research. Although the unavailability
of federal funding has not prevented all American companies from entering
the global race of human stem cell research, more resources and highly
skilled scientists like those working for the National Institutes of Health,
are needed to bring the U.S. up-to-date to compete with other countries
who had a head start.
Prohibiting stem cell research in the United States or avoiding the
controversy will not solve the ethical dilemma. The global phenomenon of
advancing knowledge and finding cures through stem cell research will not
be stopped. Had Congress been able to somehow prevent private
companies from using human stem cells, those companies would have
invested in research projects in foreign countries with more progressive
ideologies. 174 The United States needs to take charge of the situation and
move to the front of the line, before we are pushed out of the race
altogether.
166. PaegeJ, supra note 133, at 1195.
167. Thomas H. Maugh II, Treatment for Huntington's Disease Shows Promise, L.A.
TiMES, Nov. 30, 2000, at A21.
168. Id.

169. Stuart F. Brown, From Cow's Milk to Medicine Chest, FORTUNE MAG., Sept. 4, 2000,
at 52.
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174. Faye Flam & Marie McCullough, U.S. Will Pay for Stem Cell Research, PORTLAND
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Without federal funding, the private sector will continue using human
embryo stem cells for research, but it will be left to its own resources. The
effect would be slow progress compared to the rest of the world.
Absent the competitiveness of the U.S. in the race for this
important technology, other countries would certainly be in
position to reap the potentially enormous economic benefits should
they become successful with their research. The effect of this
might be likened to the type of dependency the U.S. now has on the
Organization of the Petroleum Exporting Countries (OPEC) for its
oil. 175

V. CONCLUSION
The potential medical and scientific benefits of human embryonic stem
cell research are undeniable. However, ethical controversy surrounds the
use of embryonic stem cells in research due to the special nature of the
embryo. The most accepted ethical status of embryos seems to be that
although embryos are not human persons with full rights and interests, they
still deserve respect as a form of human life. Using embryos in research
shows proper respect for them because the value of the embryo is
demonstrated through enhancing the lives of suffering people. In addition,
although adult stem cell research shows great promise, it does not hold as
much potential as embryonic stem cell research, and thus cannot serve as a
replacement. Creating embryos solely for research purposes cannot be a
viable alternative since it further complicates the ethical debate.
Considering the huge potential benefit for a great number of people and the
lack of suitable alternatives with the same benefits, human embryonic stem
cell research is more than sufficiently justified.
Federal law currently prohibits funding any research that poses a risk to
embryos. The controversy focuses on whether federal funding should be
available for research with embryonic stem cells that are arguably not even
embryos anymore. After a long turmoil of political, ethical, religious, and
scientific disputes, President Bush announced that he would allow federal
funding of embryonic stem cell research as long as the research uses preexisting stem cell lines and does not destroy any more embryos to extract
the stem cells. Although any funding is a significant step toward realizing
the full potential of embryonic stem cell research, this arbitrary restriction
has been criticized for doing the bare minimum to side with the American
popular majority.
While controversy over federal funding availability for embryonic stem
cell research continues, the private sector has been moving steadily forward
with their privately funded research. Since federal regulations do not exist
175. Paegel, supra note 133, at 1201-02.
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'outside the funding' context, the private sector remains virtually
unregulated. Despite economic restrictions hindering the private sector,
privately funded researchers have managed to produce breakthroughs in the
field. If embryonic stem cell research has to continue without federal
funding, progress will be slow.
Furthermore, because the scope of privately funded research is
unlimited and proceeds without governmental oversight, the potential for
abuse will likely increase. Withholding government funds from stem cell
research does not eliminate the moral and ethical objections. On the other
hand, federal funding confers a benefit of strictly enforced oversight
processes and creates an incentive for other private research institutions to
conform to federal ethical guidelines and regulations. With enormous
resources available, from the federal government and top National Institutes
of Health scientists at work, stem cell research will progress faster and
more efficiently under federal oversight.
The United States is currently lagging behind other countries in this
stem cell research race. Considering the unlimited potential that stem cell
research holds, we cannot delay progress because of divided ethical
OpInIOns. It is impossible to obtain a unanimous opinion on such an
important issue in a diverse society such as ours. The United States needs
to move on and focus on catching up with the rest of the world before we
are completely eliminated from the race. Federal funding provides a
solution to potential abuse in the unregulated privately funded research and
a way to keep up with the rest of the world while still ethically regUlating
stem cell research.

